Across TCGA pan-cancer cohorts, TRAJ21 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated TRAJ21 data layer compared with 13 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TRAJ21 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TRAJ21 expression acts as an unfavorable survival marker.

UCEC are the cancer types where TRAJ21 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.231	0.873	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: TRAJ21 tumor-vs-normal RNA expression · all TRAJ21 data types